Clinical Decision SupportNCT03415425
Optimizing the Influenza Clinical Decision Support Tool
A study testing Current Version of the Influenza Alert and Alternate Modifications of the Influenza Alert in people with Clinical Decision Support, run by NYU Langone Health at 1 site in United States.
Trial summary
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert. Read more about this study
- Who is it for?
- Ages 3 years and older
- Conditions the study is for
- Clinical Decision Support
- What is being tested?
- Current Version of the Influenza Alert and Alternate Modifications of the Influenza Alert
- Type of treatment
- Vaccines
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 25,881 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Jan 2018to 21 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country.
United States1 site
New York University School of Medicine
New York, New York, 10016
About this study
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
- Conditions
- Clinical Decision Support
- Being tested
- Current Version of the Influenza Alert, Alternate Modifications of the Influenza Alert
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Current Version of the Influenza AlertOther
Intervention includes the current version of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination, as part of usual care.
Alternate Modifications of the Influenza AlertOther
Intervention includes various iterations of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination.
| Study group | Role | What they receive |
|---|---|---|
| Usual Care | Active comparator | The current version of the alert will fire for this arm of the study. Receives: Other: Current Version of the Influenza Alert |
| Alert Iteration | Active comparator | A modified version of the alert will fire for this arm of the study. Receives: Other: Alternate Modifications of the Influenza Alert |
What is being measured
The primary outcome is the main question the study is designed to answer.
Alert Cancelation Rate
Number of times alert fires in medical record within 2 Month period
Measured: 2 months.
Secondary outcomes (1)
Vaccination Rate at Discharge
Number of vaccinations recorded in EMR within 2 Month period
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jan 2018
- Study start16 Jan 2018
- Primary completion7 Oct 2023
- Study completion21 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Clinical Decision SupportStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 25,881 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Leora Horwitz, MD, MHS, Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03415425
- Sponsor's protocol ID
- QI-CDS
- Status last verified
- Mar 2024
- First submitted
- 26 Dec 2017
- Last updated
- 1 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Austrian J, Mendoza F, Szerencsy A, Fenelon L, Horwitz LI, Jones S, Kuznetsova M, Mann DM. Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials. J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651.
PubMed 33835035
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimizing the Influenza Clinical Decision Support Tool
- ClinicalTrials.gov ID
- NCT03415425
- Acronym / sponsor ID
- QI-CDS
- Conditions
- Clinical Decision Support
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 25,881 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- 16 Jan 2018 (actual)
- Primary completion
- 7 Oct 2023 (actual)
- Study completion
- 21 Nov 2023 (actual)
- First posted
- 30 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Usual Care | Active comparator | Other: Current Version of the Influenza AlertThe current version of the alert will fire for this arm of the study. |
| Alert Iteration | Active comparator | Other: Alternate Modifications of the Influenza AlertA modified version of the alert will fire for this arm of the study. |
Who may qualify
- Ages
- 3 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Current Version of the Influenza AlertIntervention includes the current version of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination, as part of usual care. | Other | Usual Care |
| Alternate Modifications of the Influenza AlertIntervention includes various iterations of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination. | Other | Alert Iteration |
Primary outcome
Alert Cancelation Rate
Time frame: 2 months.
Number of times alert fires in medical record within 2 Month period
1 secondary outcome
Vaccination Rate at Discharge
Time frame: 2 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2024.
- Derived from this study: PubMed 33835035Austrian J, Mendoza F, Szerencsy A, Fenelon L, Horwitz LI, Jones S, Kuznetsova M, Mann DM. Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials. J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651.
- Individual participant dataSharing planned: Undecided
Related trials for Clinical Decision Support
Recruiting
A Multicenter Randomized Trial of CT-Based AI Decision Support for Early Pneumonia Care
Pneumonia; Pulmonary Infection
Not yet recruitingObservational study
Explainable AI for Prospective Pressure Injury Staging
Pressure Injury
Not yet recruiting
AI-Assisted Systemic Health Risk Assessment in General Ophthalmology: A Cluster Randomized Trial
Systemic Health Risk
Not yet recruiting
Artificial Intelligence (AI)-Initiated Clinical Decision Support in Hospitalist Practice
Clinical Decision Support
Not yet recruiting
Sleep MAPP in the Polytrauma/TBI System of Care
Insomnia Disorder, Mild Traumatic Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Leora Horwitz, MD, MHS principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Current Version of the Influenza Alert and Alternate Modifications of the Influenza Alert in people with Clinical Decision Support, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Alert Cancelation Rate (time frame: 2 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03415425, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2024.